NCT04914221

The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers

A Randomized, Open-label, Single-dose, Replicate Crossover Study to Compare the Pharmacokinetics and Safety in Healthy Adult Volunteers Following Oral Administration of JLP-2002

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 42 (actual)
• Sponsor: Jeil Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

A randomized, open-label, single-dose, replicate crossover study to compare the pharmacokinetics and safety in healthy adult volunteers following oral administration of JLP-2002

Detailed description

A randomized, open-label, single-dose, replicate crossover study

Conditions

• Overactive Bladder(OAB)

Interventions

Type	Name	Description
DRUG	JLP-2002	administration of JLP-2002
DRUG	Comparator	administration of comparator

Timeline

• Start date: 2021-03-13
• Primary completion: 2021-05-26
• Completion: 2021-05-26
• First posted: 2021-06-04
• Last updated: 2021-06-14

Locations

1 site across 1 country: South Korea